Amneal Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 7.7K
- Market Cap
- $2.6B
- Website
- http://www.amneal.com
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
Phase 3
Completed
- Conditions
- PainUrinary Tract Infections
- Interventions
- Drug: Phenazopyridine HydrochlorideDrug: Placebo
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 233
- Registration Number
- NCT01064024
- Locations
- 🇺🇸
Oxford Pharmaceutical Resources, Inc., Totowa, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath